← All organizations

Kresge Eye Institute

Academic/HospitalWebsite ↗

Also known as: Kresege Eye Institute | Kresge Eye Institute

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Oct 1, 2017

Timeline

1940s

Jan 1, 1948
Kresge Eye Institute— Founded

Drugs by trial phase (5 distinct, 5 trials)

Phase 4 (1 own, 0 via acquisition)

fluorescein

Phase 2 (1 own, 0 via acquisition)

thymosin beta-4

Phase 1 (1 own, 0 via acquisition)

triamcinolone

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT03244982Lead sponsorPhase 4Oct 1, 2017
NCT03244982Overall official - principal investigatorPhase 4Oct 1, 2017
NCT01428388CollaboratorN/ASep 1, 2011
NCT01393132CollaboratorPhase 2Mar 1, 2011
NCT00618644Overall official - principal investigatorN/AJan 1, 2010
NCT00618644Lead sponsorN/AJan 1, 2010
NCT00915837Overall official - principal investigatorPhase 1Jun 1, 2005

Details

Founded: Detroit, MI, US Jan 1, 1948
Last known activity: Oct 1, 2017